Tonsillitis
Showing 76 - 100 of 1,749
Jansky-Bielschowsky Disease, Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 Trial in Worldwide (BMN 190,
Completed
- Jansky-Bielschowsky Disease
- +4 more
- BMN 190
- Intracerebroventricular (ICV) access device
-
Columbus, Ohio
- +3 more
Jul 28, 2022
Peritonsillar Abscess, Surgical Incision Trial (Medical Management Alone Arm, Surgical Arm)
Not yet recruiting
- Peritonsillar Abscess
- Surgical Incision
- Medical Management Alone Arm
- Surgical Arm
- (no location specified)
Aug 3, 2021
Microbial Colonization Trial in Dunedin (Streptococcus salivarius K12 lozenge, Probiotic S. salivarius K12 lozenges containing
Recruiting
- Microbial Colonization
- Streptococcus salivarius K12 lozenge
- +11 more
-
Dunedin, Otago, New ZealandBlis Technologies Ltd
May 11, 2022
Enzyme Deficiency in Pulmonology Clinics (ADA)
Active, not recruiting
- Bronchiectasis
- +2 more
- adenosine deaminase enzyme deficiency test
-
Ankara, Mamak, TurkeyAnkara University Medical Faculty
Mar 18, 2022
Treatment of Pediatric Outpatients With Respiratory Diseases
Recruiting
- Respiratory Diseases
-
Beijing, Beijing, ChinaBaoping Xu
Apr 20, 2021
Adenosine Deaminase Enzyme Deficiency Disease in Adult Pulmonary
Enrolling by invitation
- Pulmonary Alveolar Proteinosis
- adenosine deaminase test
-
Istanbul, Maltepe, TurkeyIstanbul Yedikule Chest Diseases and Thoracic Surgery Training a
Mar 18, 2022
TBI-Traumatic Brain Injury Trial in Seattle (simvastatin, Placebo Oral Tablet)
Completed
- TBI-Traumatic Brain Injury
- simvastatin
- Placebo Oral Tablet
-
Seattle, WashingtonVA Puget Sound Health Care System Seattle Division, Seattle, WA
Nov 17, 2021
Tonsillectomy Trial in Gødstrup (BiZact, Cold Steel)
Recruiting
- Tonsillectomy
- BiZact
- Cold Steel
-
Gødstrup, DenmarkLine Schiøtt Nissen
Feb 25, 2022
Adenotonsillar Hypertrophy, Obstructive Sleep Apnea, Sleep-Disordered Breathing Trial in Saint Louis (Ketorolac)
Recruiting
- Adenotonsillar Hypertrophy
- +3 more
-
Saint Louis, MissouriSSM Cardinal Glennon Children's Hospital
Feb 20, 2022
Pain Trial in Marburg (Touch Intervention, Control)
Recruiting
- Pain
- Touch Intervention
- Control
-
Marburg, GermanyGermany Philipps University
Oct 10, 2023
COVID-19 Trial in Santiago De Los Caballeros (Bactek-R)
Active, not recruiting
- COVID-19
- Bactek-R
-
Santiago De Los Caballeros, Dominican RepublicHospital Metropolitano Santiago
Nov 10, 2021
Healthy Volunteers Trial in Vienna (Ocular gel)
Completed
- Healthy Volunteers
- Ocular gel
-
Vienna, AustriaDepartment of Clinical Pharmacology
Mar 8, 2022
Peanut Allergy Trial in Worldwide (AR101 powder provided in capsules & sachets, Placebo powder provided in capsules & sachets)
Completed
- Peanut Allergy
- AR101 powder provided in capsules & sachets
- Placebo powder provided in capsules & sachets
-
Tucson, Arizona
- +68 more
Mar 16, 2022
Recurrent Vulvovaginal Candidiasis Trial in United States (Oteseconazole (VT-1161), Placebo)
Completed
- Recurrent Vulvovaginal Candidiasis
- Oteseconazole (VT-1161)
- Placebo
-
Phoenix, Arizona
- +13 more
Dec 17, 2021
Cardiac Iron Overload Trial in Worldwide (Deferasirox and Deferoxamine)
Completed
- Cardiac Iron Overload
- Deferasirox and Deferoxamine
-
Toronto, Ontario, Canada
- +14 more
Jul 23, 2021
Immune Response Trial (MV130, Placebo)
Not yet recruiting
- Immune Response
- MV130
- Placebo
- (no location specified)
Mar 23, 2022
Moderate to Severe Plaque Psoriasis Trial in Saint Petersburg (BCD-085 Q2W, BCD-085 Q4W, Placebo)
Completed
- Moderate to Severe Plaque Psoriasis
- BCD-085 Q2W
- +2 more
-
Saint Petersburg, Strelna, Russian FederationBIOCAD
May 11, 2022
Recurrent Tonsillitis, Obstructive Sleep Apnea, Sleep Disordered Breathing Trial in Atlanta (Ibuprofen,
Terminated
- Recurrent Tonsillitis
- +3 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta (CHOA)
Mar 28, 2018
Primary Hyperoxaluria Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes HC-1, Placebo)
Completed
- Primary Hyperoxaluria
- Oxabact OC5 - Oxalobacter formigenes HC-1
- Placebo
-
Nashville, Tennessee
- +9 more
Dec 9, 2021
Influenza Trial in United Kingdom, United States (Fluzone Quadrivalent vaccine, No Preservative)
Completed
- Influenza
- Fluzone Quadrivalent vaccine, No Preservative
-
Birmingham, Alabama
- +35 more
Mar 15, 2022
Migraine Trial in Sendai (Each subject will subcutaneously self-administer TEV 48125 at 225 mg/1.5 mL (150 mg/mL) once monthly
Completed
- Migraine
- Each subject will subcutaneously self-administer TEV 48125 at 225 mg/1.5 mL (150 mg/mL) once monthly for a total of 2 doses.
-
Sendai, JapanSendai Zutsu No-Shinkei Clinic
Oct 26, 2021